Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454.
about
Deadly allies: the fatal interplay between platelets and metastasizing cancer cellsInteraction between circulating cancer cells and platelets: clinical implicationAnti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparinP-selectin-mediated platelet activation promotes adhesion of non-small cell lung carcinoma cells on vascular endothelial cells under flowA new hypothesis: some metastases are the result of inflammatory processes by adapted cells, especially adapted immune cells at sites of inflammation.Pretreatment platelet count as a predictor for survival and distant metastasis in nasopharyngeal carcinoma patients.Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation.P-Selectin-Mediated Adhesion between Platelets and Tumor Cells Promotes Intestinal Tumorigenesis in Apc(Min/+) Mice.Engagement of αIIbβ3 (GPIIb/IIIa) with ανβ3 integrin mediates interaction of melanoma cells with platelets: a connection to hematogenous metastasis.P-selectin-mediated platelet adhesion promotes tumor growth.Chemotherapy Response Rates Among Patients With Endometrial Cancer Who Have Elevated Serum Platelets.Platelets and metastasis revisited: a novel fatty link.A humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor microenvironment.Inhibition of MCF-7 breast cancer cell-induced platelet aggregation using a combination of antiplatelet drugs.Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasisSkeletal metastasis: treatments, mouse models, and the Wnt signaling.Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.Do circulating tumor cells play a role in coagulation and thrombosis?Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization.Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?Platelet Integrins in Tumor Metastasis: Do They Represent a Therapeutic Target?Pretreatment platelet count as a prognostic factor in patients with pancreatic cancer: a systematic review and meta-analysis.The Potential Role of Senescence As a Modulator of Platelets and Tumorigenesis.Tamoxifen Directly Inhibits Platelet Angiogenic Potential and Platelet-Mediated Metastasis.Human Cancer and Platelet Interaction, a Potential Therapeutic Target.Role of platelets and platelet receptors in cancer metastasisNovel antibodies against GPIbα inhibit pulmonary metastasis by affecting vWF-GPIbα interaction
P2860
Q24623647-AF212D09-FAB5-45FE-80DF-A4292B0AEB19Q26778920-1F6891E7-708D-49A2-9062-FE4C0211B05AQ33373462-27B972AF-45AB-4EA3-A57F-CC00F42D32E2Q34135244-98081236-EEDC-4496-AC41-95118C02B0EDQ34525712-C3268D70-0AF0-4052-9A7A-D7428471905CQ35042007-0B09BD58-E9B0-4717-90B1-222DBFBF6BD5Q35048404-625E47A3-D618-4924-92C1-4B9EEDDFCB15Q35632734-50D099D7-F72E-41CA-BE61-5E49685D590AQ35694069-C7BEECB7-874F-4956-A5CA-E67D1B85199FQ35740033-7CF0977C-F8A8-4BA7-86B1-4265ACFEC70FQ35769337-84D8359E-518F-47B5-BEC9-F548BD49191DQ35984309-A07AD503-027B-479B-8E8D-54AB59A77A71Q36305346-A1C12CA1-F05C-4E4A-8604-DBE5449B57B1Q36611493-DEE5C55B-57E4-42A7-8231-CCD68511A093Q36618989-B030A48C-52CC-4CDA-979B-E9C04C637A0AQ37354085-BF15076F-AF33-4E9E-B694-63BEA6D69476Q37700375-A03BA500-B128-4D74-87A7-830740DEAB17Q38042949-1ACC099A-C8B9-4786-BF91-77976B03C9F0Q40448208-89B66304-8619-4F36-902B-ECDB6CFBEF59Q41420993-E13E1E79-FA36-4B8D-8A76-86900FB2FB0BQ44522050-D2B669B7-1B0A-40C3-AC46-D5B72482250DQ49513468-A031DAA4-3098-417B-91BC-4FE62514AF01Q50143864-5AA8C526-0678-4501-B755-13030CEA4B70Q51155744-A184AFDF-1ED0-4132-B774-F03E9BD00006Q52717949-82F88274-FA53-4100-B1D6-2CB896C560EAQ57280930-3074EB72-FD76-4543-8BCB-43413B0D1D39Q58732980-253AA432-C806-43CE-9B9D-0C0C2976E2A1
P2860
Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Inhibition of tumor cell-induc ...... l GpIIb/IIIa antagonist XV454.
@ast
Inhibition of tumor cell-induc ...... l GpIIb/IIIa antagonist XV454.
@en
type
label
Inhibition of tumor cell-induc ...... l GpIIb/IIIa antagonist XV454.
@ast
Inhibition of tumor cell-induc ...... l GpIIb/IIIa antagonist XV454.
@en
prefLabel
Inhibition of tumor cell-induc ...... l GpIIb/IIIa antagonist XV454.
@ast
Inhibition of tumor cell-induc ...... l GpIIb/IIIa antagonist XV454.
@en
P2093
P356
P1476
Inhibition of tumor cell-induc ...... l GpIIb/IIIa antagonist XV454.
@en
P2093
Ali Amirkhosravi
Hina Desai
John L Francis
Mildred Amaya
Shaker A Mousa
Susan Blaydes
Todd Meyer
P304
P356
10.1160/TH03-02-0102
P577
2003-09-01T00:00:00Z